A drug originally designed for the treatment of Ebola appears to be gradually getting global endorsement for the treatment of coronavirus. Early last week, the United States (US) announced that it had arranged for the entire stock of Remdesivir for the next three months to be delivered to it.
US is among the countries worst hit by coronavirus otherwise known as Covid-19.
The European Union (EU), on its part, at the weekend, approved the use of the drug to treat severe cases of coronavirus.
There is, of recent, a spike in the cases of coronavirus in the country, especially since the lockdown was eased and testing for the virus scaled up.
The latest high profile case of the virus is the governor of Ebonyi State, Dave Umahi, who was announced to have contracted the disease yesterday.
Former governor of Oyo State, Senator Abiola Ajimobi, also died penultimate week apparently from complications arising from Covid-19 infection.
- The Director-General of the Nigerian Centre for Disease Control (NCDC), Dr Chikwe Ihekweazu spoke on the global endorsement of Remdevisir for coronavirus, even if on limited scale, said while Nigeria would continue to monitor emerging evidence from various clinical trials across the world, the review of the country is guidelines and treatment protocol would be guided by scientific evidence.